| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/20/2007 | US20070219148 Small Interfering RNA Specific to Sub-Units $g(a),$g(a)' and $g(b) of the Kinase Protein ck2,and the Applications of the Same |
| 09/20/2007 | US20070219140 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 09/20/2007 | US20070219139 Immune-modulating peptide |
| 09/20/2007 | US20070219138 Compositions capable of reducing elevated blood urea concentration |
| 09/20/2007 | US20070219137 Novel Potassium Channel Modulator Peptide |
| 09/20/2007 | US20070219136 Methods and compositions for treating inflammatory disorders |
| 09/20/2007 | US20070219135 Pharmaceutical Composition Comprising Factor VII Polypeptides and PAI-1 Polypeptide |
| 09/20/2007 | US20070219134 Lymphatic zip codes in tumors and pre-malignant lesions |
| 09/20/2007 | US20070219133 CD52 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION |
| 09/20/2007 | US20070219132 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 09/20/2007 | US20070219131 Compositions capable of facilitating penetration across a biological barrier |
| 09/20/2007 | US20070219130 Administering an effective amount of a SLURP-1 polypeptide of SEQ ID NO: 2; analegsics; neuregulins, promoting the the amplitude of acetylcholine-evoked macroscopic currents; nervous system disorders; neuroprotectants; skindisorders |
| 09/20/2007 | US20070219129 hsp90 decoy peptides and uses thereof |
| 09/20/2007 | US20070219128 Medical and health-care uses of pufferfish type I collagen extract and processes for producing said extract |
| 09/20/2007 | US20070219127 Cyclosporin a compositions |
| 09/20/2007 | US20070219126 Class of bioactive glycoprotein |
| 09/20/2007 | US20070219125 Novel thrombospondin-1 polynucleotides encoding variant thrombospondin-1 polypeptides and methods using same |
| 09/20/2007 | US20070219124 includes cyclodextrins; amphomycins, friulimicins; side effect reduction |
| 09/20/2007 | US20070219123 Selective n-acylation of a82846 glycopeptide analogs |
| 09/20/2007 | US20070219121 Vasodilator pharmaceutical preparation and health food composition |
| 09/20/2007 | US20070219120 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 09/20/2007 | US20070219119 Method of Treatment of Tendonitis by Administration of Streptolysin O |
| 09/20/2007 | US20070219118 Therapeutic methods for nucleic acid delivery vehicles |
| 09/20/2007 | US20070219117 Bidentate motif and methods of use |
| 09/20/2007 | US20070219116 Follicle Stimulating Hormone Superagonists |
| 09/20/2007 | US20070219115 Pharmaceutical Uses of Bisphosphonates |
| 09/20/2007 | US20070219114 Preventives or Remedies for Hepatopathy |
| 09/20/2007 | US20070218549 Compositions comprising conditioned cell culture media and uses thereof |
| 09/20/2007 | US20070218527 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218504 Human leptin-derived polypeptides and uses thereof |
| 09/20/2007 | US20070218142 Pharmaceutical Formulations For The Prolonged Release Of Interleukins And Their Therapeutic Applications |
| 09/20/2007 | US20070218138 Pharmaceutical Compositions |
| 09/20/2007 | US20070218131 Effervescent formulations comprising desmopressin |
| 09/20/2007 | US20070218121 Compounds that inhibit caspase activity for treating glaucoma |
| 09/20/2007 | US20070218118 Methods and compositions for treating post- myocardial infarction damage |
| 09/20/2007 | US20070218117 Supra molecular construct for delivery of interferon to a mammal |
| 09/20/2007 | US20070218105 Topical Treatment with NGF and DHA in Damaged Corneas |
| 09/20/2007 | US20070218085 Botulinum toxin therapy for neuropsychiatric disorders |
| 09/20/2007 | US20070218080 Peptide antigen of human papillomavirus type 16 and application thereof |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218074 Vaccine mixture comprising e6/e7 human papilloma viral amino acid sequences for use as therapeutic targeting tools in treatment of uterine cancer |
| 09/20/2007 | US20070218073 Antigenic composition |
| 09/20/2007 | US20070218071 Novel therapeutic targets in cancer |
| 09/20/2007 | US20070218070 Methods of modulation of the immune system |
| 09/20/2007 | US20070218066 For clinical screening, diagnosis, prognosis, therapy and prophylaxis of conditions involving the pathology of epithelial cells and particularly those of the alimentary canal |
| 09/20/2007 | US20070218057 Human Obesity Susceptibility Gene and Uses Thereof |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218051 Epitope peptides immunogenic against Streptococcus pneumoniae |
| 09/20/2007 | US20070218048 Sfec, a Sperm Flagellar Energy Carrier Protein |
| 09/20/2007 | US20070218046 Method of enhancing degradation of chitin |
| 09/20/2007 | US20070218045 Cucumis melo protein extract, which gives the best possible results in terms of limiting, or even stopping, skin depigmentation, which is easy to produce, stable and economical, and exhibits no inopportune effects of release; for preventing development of the inflammation during vitiligo |
| 09/20/2007 | US20070218044 Decomposition and modification of silicate and silicone by silicase and use of the reversible enzyme |
| 09/20/2007 | US20070218043 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
| 09/20/2007 | US20070218042 Vitamins B2, B6, B12, Mg, glucosamine sulfate, dimethylsulfone, and chondroitin sulfate; thromboxane B2 antagonist; migraines, arthritis, fibromyalgia |
| 09/20/2007 | US20070218033 Composition and method of treating hepatitis C |
| 09/20/2007 | US20070218032 B7-h4 expression on tumor vasculature |
| 09/20/2007 | US20070218031 Candidate drug which inhibits the interaction between AICD and p53 in neurons is selected as a drug for the prevention and/or treatment of Alzheimer's disease; provides treatment of Alzheimer's disease based on a different Alzheimer's disease onset mechanism from the amyloid hypothesis |
| 09/20/2007 | US20070218026 DNA encoding the human serine protease EOS |
| 09/20/2007 | US20070218012 Spray drying a drug such as telaprevir; VX 770 is excluded; including a nonvolatile solvent during spray drying of a drug can improve the properties of resulting product |
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | US20070218001 Biotherapeutics, Diagnostics and Research Reagents |
| 09/20/2007 | DE4003844B4 Neue Cyclosporin enthaltende galenische Formulierungen New cyclosporin-containing pharmaceutical formulations |
| 09/20/2007 | DE202006012340U1 Pharmazeutische Zusammensetzung, insbesondere zur Anwendung bei Nahrungsmittelunverträglichkeiten A pharmaceutical composition, in particular for use in food intolerances |
| 09/20/2007 | CA2680736A1 Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
| 09/20/2007 | CA2680690A1 Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia |
| 09/20/2007 | CA2649261A1 Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent |
| 09/20/2007 | CA2646931A1 Combination of cytokine and cytokine receptor for altering immune system functioning |
| 09/20/2007 | CA2646438A1 Methods and compositions for treatment of diastolic heart failure |
| 09/20/2007 | CA2646419A1 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases |
| 09/20/2007 | CA2646316A1 Methods of treating muscular wasting diseases using nf-kb activation inhibitors |
| 09/20/2007 | CA2646285A1 Compositions and methods for treating ophthalmic disorders. |
| 09/20/2007 | CA2645810A1 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement |
| 09/20/2007 | CA2645676A1 Use of caspases for the preparation of medicaments |
| 09/20/2007 | CA2645674A1 Pharmaceutical compositions comprising sods and prolamine based peptide fragments |
| 09/20/2007 | CA2645345A1 Medicaments and proteins based on tgf-beta monomers for the treatment of wounds |
| 09/20/2007 | CA2645342A1 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
| 09/20/2007 | CA2645308A1 Enzyme-containing candy |
| 09/20/2007 | CA2643693A1 Formulations for ecallantide |
| 09/20/2007 | CA2643389A1 Method for solubilising, dispersing and stabilising of substances |
| 09/20/2007 | CA2643239A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |
| 09/20/2007 | CA2638862A1 Pegylated mutated clostridium botulinum toxin |
| 09/19/2007 | EP1835030A1 OB fusion protein compositions and methods |
| 09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
| 09/19/2007 | EP1834963A1 Di-polymer protein conjugates and processes for their preparation |
| 09/19/2007 | EP1834962A1 PEGylated mtutated Clostridium botulinum toxin |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834647A1 Canine and equine collagen joint health supplement |
| 09/19/2007 | EP1834267A2 Pf4 pharmacophores and their uses |
| 09/19/2007 | EP1833993A2 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 09/19/2007 | EP1833991A2 Trefoil factors and methods of treating proliferation disorders using same |
| 09/19/2007 | EP1833978A1 Tripeptide and tetrapeptide thioethers |
| 09/19/2007 | EP1833964A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 09/19/2007 | EP1833847A2 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides |
| 09/19/2007 | EP1833844A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 09/19/2007 | EP1833842A1 Tripeptide and tetrapeptide sulfones |
| 09/19/2007 | EP1833838A2 Cationic liposomes comprising a charge neutral compound and a cationic phospholipid |
| 09/19/2007 | EP1833569A2 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 09/19/2007 | EP1833505A1 Local treatment of bone defects with matrix releasing bmp or pth |